CD8A and infection: The ability of CD8+ cells to suppress replication of SIV derived from pre-ART PBMCs (anti-pre-ART SIV CD8+ cell efficacy) was examined by using pre-ART CD8- cells obtained at week 10 post-infection from individual animals as the target cells.